ArticleCurrent medical imaging2025
Preoperative CT-based Intratumoral and Peritumoral Radiomics Prediction for Vasculogenic Mimicry in Lung Adenocarcinoma.
Article in Current medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study seeks to assess vasculogenic mimicry (VM) occurrence in lung adenocarcinoma (LUAD) by delineating intratumoral and peritumoral characteristics using preoperative CT-based radiomics and a nomogram for enhanced precision. MATERIALS AND
methodsOur retrospective analysis enrolled 150 LUAD patients, ascertained their VM status, and stratified them randomly into development (n=105) and validation cohorts. We extracted radiomics features from intra- and peritumoral zones, delineating 3, 5, and 7mm expansions on thin-section chest CT images. We formulated logistic models encompassing a clinical model (CM), intratumoral radiomics model (TRM), peritumoral radiomics models at 3, 5, and 7 mm (PRMs), and a composite model integrating both intra- and peritumoral zones (CRM). A radiomics nomogram model (RNM) was devised, amalgamating the Rad-scores from intra- and peritumoral regions with clinical-radiological traits to forecast VM. The models' efficacy was gauged via the receiver operating characteristic (ROC) curve analysis, calibration assessment, and decision curve analysis (DCA).
resultsThe CRM outperformed its counterparts, the TRM, PRM_3mm, PRM_5mm, and PRM_7mm models, with AUCs reaching 0.859 and 0.860 in the development and validation cohorts. Within the CM, tumor size and spiculation emerged as significant predictive covariates. The RNM, integrating independent predictors with the CRM-Rad-score, demonstrated clinical utility, achieving AUCs of 0.903 and 0.931 in the respective cohorts.
conclusionOur findings underscore the potential of CT-based radiomics characteristics derived from intratumoral and peritumoral regions to assess VM presence in LUAD patients. Combining radiomics signatures with clinicoradiological parameters within a nomogram framework significantly enhances predictive accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.